OA10287A - 2- (Pyrazol-3-yl) carbapenem derivatives - Google Patents

2- (Pyrazol-3-yl) carbapenem derivatives Download PDF

Info

Publication number
OA10287A
OA10287A OA60822A OA60822A OA10287A OA 10287 A OA10287 A OA 10287A OA 60822 A OA60822 A OA 60822A OA 60822 A OA60822 A OA 60822A OA 10287 A OA10287 A OA 10287A
Authority
OA
OAPI
Prior art keywords
carbapen
carboxylate
sodium
group
methyl
Prior art date
Application number
OA60822A
Other languages
English (en)
Inventor
Steven Coulton
Jeremy David Hinks
Eric Hunt
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939322284A external-priority patent/GB9322284D0/en
Priority claimed from GB9410929A external-priority patent/GB9410929D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA10287A publication Critical patent/OA10287A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA60822A 1993-10-29 1996-04-26 2- (Pyrazol-3-yl) carbapenem derivatives OA10287A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939322284A GB9322284D0 (en) 1993-10-29 1993-10-29 Novel compounds
GB9410929A GB9410929D0 (en) 1994-06-01 1994-06-01 Novel compounds

Publications (1)

Publication Number Publication Date
OA10287A true OA10287A (en) 1997-10-07

Family

ID=26303758

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60822A OA10287A (en) 1993-10-29 1996-04-26 2- (Pyrazol-3-yl) carbapenem derivatives

Country Status (22)

Country Link
US (1) US5612477A (de)
EP (1) EP0725783B1 (de)
JP (1) JP3703146B2 (de)
KR (1) KR960705827A (de)
CN (1) CN1167486A (de)
AP (1) AP9600800A0 (de)
AT (1) ATE229957T1 (de)
AU (1) AU697108B2 (de)
BG (1) BG100551A (de)
BR (1) BR9407889A (de)
CA (1) CA2175054C (de)
CZ (1) CZ122996A3 (de)
DE (1) DE69431919T2 (de)
ES (1) ES2188621T3 (de)
FI (1) FI961817A (de)
HU (1) HUT75519A (de)
NO (1) NO961654L (de)
NZ (1) NZ274878A (de)
OA (1) OA10287A (de)
PL (1) PL314173A1 (de)
SK (1) SK53696A3 (de)
WO (1) WO1995011905A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020147333A1 (en) 1993-10-29 2002-10-10 Smithkline Beecham P.L.C. 2-(pyrazol-3-yl)carbapenem derivatives
EP0785937A1 (de) * 1994-10-14 1997-07-30 Smithkline Beecham Plc 2-(imidazol-4-yl)carbapenemderivate, ihre zwischenprodukte und verwendung als antibakterielle mittel
MX9708422A (es) * 1995-05-03 1998-02-28 Smithkline Beecham Plc Esteres de carbapenemas.
IL118092A0 (en) * 1995-05-03 1996-09-12 Smithkline Beecham Plc Antibacterial compounds their preparation and pharmaceutical compositions containing them
GB0400329D0 (en) * 2004-01-08 2004-02-11 Glaxo Group Ltd Novel processes
GB0400405D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes
JP2007039383A (ja) * 2005-08-03 2007-02-15 Dainippon Sumitomo Pharma Co Ltd アリールカルバペネム化合物の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
EP0430037A3 (en) * 1989-11-21 1992-05-27 Banyu Pharmaceutical Co., Ltd. Process for producing 2-carbon-substituted carbapenem derivatives
CA2036960A1 (en) * 1990-02-26 1991-08-27 Thomas A. Rano Novel synthesis of carbapenem intermediates
JP3233434B2 (ja) * 1992-04-01 2001-11-26 塩野義製薬株式会社 カルバペネム誘導体

Also Published As

Publication number Publication date
AU697108B2 (en) 1998-09-24
JPH09504285A (ja) 1997-04-28
KR960705827A (ko) 1996-11-08
CZ122996A3 (en) 1996-10-16
FI961817A (fi) 1996-06-28
NZ274878A (en) 1998-02-26
AU7997594A (en) 1995-05-22
CN1167486A (zh) 1997-12-10
NO961654D0 (no) 1996-04-25
PL314173A1 (en) 1996-08-19
JP3703146B2 (ja) 2005-10-05
WO1995011905A1 (en) 1995-05-04
EP0725783B1 (de) 2002-12-18
ES2188621T3 (es) 2003-07-01
US5612477A (en) 1997-03-18
ATE229957T1 (de) 2003-01-15
HU9601097D0 (en) 1996-07-29
DE69431919T2 (de) 2003-11-13
EP0725783A1 (de) 1996-08-14
CA2175054A1 (en) 1995-05-04
SK53696A3 (en) 1996-10-02
FI961817A0 (fi) 1996-04-29
AP9600800A0 (en) 1996-04-30
HUT75519A (en) 1997-05-28
BR9407889A (pt) 1996-10-29
DE69431919D1 (de) 2003-01-30
NO961654L (no) 1996-06-11
CA2175054C (en) 2005-07-12
BG100551A (en) 1997-01-31

Similar Documents

Publication Publication Date Title
JP2792103B2 (ja) 3―ピロリジニルチオ―1―アザビシクロ[3.2.0]ヘプト―2―エン―2―カルボン酸化合物
US5004739A (en) 2-phenanthrenyl carbapenem antibacterial agents
WO2000006581A1 (fr) Nouveaux derives de carbapenem
OA10287A (en) 2- (Pyrazol-3-yl) carbapenem derivatives
WO2002040483A1 (fr) Dérivés 1-méthylcarbapenem
JPH10507185A (ja) 2−(イミダゾール−4−イル)カルバペネム誘導体、その中間体および抗菌剤としての使用
US5606051A (en) 2-(pyrazol-3-yl)carbapenem derivatives
JPS6222786A (ja) 複素環メチレンペネム化合物、その製造法および抗菌組成物
US7045619B2 (en) 2-(pyrazol-3-yl)carbapenem derivatives
JPH05105681A (ja) 2−(9−フルオレノニル)−カルバペネム
US5384317A (en) Bridged biphenyl carbapenem compounds, compositions containing such compounds and methods of use
US5116833A (en) Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof
MXPA97008422A (en) Carbapene steres
EP0337643A2 (de) 6-Substituierte Acrylamido-Penizillansäure-Derivate, Herstellung und Verwendung
WO1996034869A1 (en) Esters of carbapenems
JP2002212182A (ja) 1−メチルカルバペネム誘導体
IE921546A1 (en) Chemical compounds
US5372993A (en) Bridged carbapenem compounds, compositions containing such compounds and methods of use
JPH09503518A (ja) 3−ピロリジニルチオ−カルバペネム誘導体およびそれらの抗菌活性
WO1996034868A1 (en) Esters of carbapenems
JPH05105680A (ja) 2−フエナントレニルカルバペネム類
JPH05213955A (ja) (n−ピリジニウムフェニル)−カルバペネム
JPH04234886A (ja) 1−アザビシクロ[3.2.0]ヘプト−2−エン−2−カルボン酸化合物
JPH0242081A (ja) 3―ピロリジニオチオ‐1‐アザビシクロ[3.2.0.]ヘプト‐2‐エン‐2‐カルボキシレート化合物およびその製造方法